Instrument Inactif

Autres langues PLC Systems Inc. OTC Bulletin Board

Actions

PLCSF

CA69341D1042

Equipement et technologie médicale avancés

Cours en clôture OTC Bulletin Board
- ^USD	-

25/07/23	InMode Ltd. (NasdaqGS:INMD) a acquis les actifs de propriété intellectuelle de Viveve Medical Inc.	CI
17/01/23	Mise à jour sectorielle : Les actions du secteur de la santé terminent près des planchers intrajournaliers	MT

Autres langues

25/07/23	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.
23/01/23	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index
18/01/23	VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
18/01/23	Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index
17/01/23	Sector Update: Health Care Stocks Finishing Near Intra-Day Lows
17/01/23	Top Midday Decliners
17/01/23	Investors Digest More Big Bank Earnings, Weighing on US Equity Futures
17/01/23	Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday
17/01/23	Top Premarket Decliners
17/01/23	Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq
17/01/23	Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
17/01/23	Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K
17/01/23	VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)
17/01/23	Viveve Medical to Seek Strategic Alternatives
15/12/22	VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
15/12/22	Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence
02/12/22	VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
01/12/22	VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
23/11/22	VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
10/11/22	VIVEVE MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
10/11/22	Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
10/11/22	Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.7M
27/10/22	Viveve Medical, Inc. announced that it has received $0.014675 million in funding
14/10/22	Viveve Medical, Inc. announced that it expects to receive $0.014675 million in funding
04/10/22	VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)